Joan N. Ericksen

Ameriprise Money Market (AIMMA) — None — Sold

Credit Suisse Commodity Return Strategy Cl AICRSAX) — None — Sold

Fidelity Advisor 529 Aggressive Growth C1 C(FFCGX) — None — Sold (part)

Schwab Intl Equity ETF (SCHF) — Int/Div — Sold

Trust #1 (H)

Charles Schwab Cash (cash account) — Interest — Open

Columbia Acorn Intl C1 A (LAIAX) — None — Sold

Eagle Small Cap Growth C1 A (HRSCX) — None — Sold

Oppenheimer Developing Markets C1 A (ODMAX) — None — Sold

Oppenheimer Steelpath MLP Select 40 C1 A — Int/Div — Sold

Vanguard FTSE Developed Markets ETF (VEA) — Int/Div — Sold

Vanguard Mid Cap Value ETF (VOE) — Int/Div — Sold

Vanguard Mid Cap Growth ETF (VOT) — Int/Div — Sold

Vanguard Growth ETF (VUG) — Int/Div — Sold

Vanguard Value ETF (VTV) — Int/Div — Sold

Accenture PLC Class A — Int/Div — Buy

Adient PLC — None — Buy

Adient PLC — Sold

Check PT Software — None — Buy

Cognizant Tech Solu Class A — None — Buy

CR Bard Incorporate — Int/Div — Buy

CVS Health Corp — Int/Div — Buy

Danaher Corp — None — Buy

Ecolab Inc — Int/Div — Buy

Expeditors Intl Wash — Int/Div — Buy

Fastenal Co — Int/Div — Buy

Fedex Corporation — Int/Div — Buy

Franklin Resources — None — Buy

Minois Tool Works — None — Buy

Johnson & Johnson — Int/Div — Buy

Johnson Ctls Intl — None — Buy

Medtronic PLC — Int/Div — Buy

Microsoft Corp — Int/Div — Buy

Novartis AG ADR — None — Buy

Proctor & Gamble — Int/Div — Buy

Qualcomm Inc — Int/Div — Buy

Sherwin Williams Co — Int/Div — Buy

Stryker Corp — None — Buy

Thermo Fisher Scientific — Int/Div — Buy

Visa Inc Class A — Int/Div — Buy

Wal-mart Stores Inc — Int/Div — Buy

WW Grainger Inc — Int/Div — Buy

IRA #1 (H)

Charles Schwab Cash ( cash account) — Interest — Open

Goldman Sachs Commodity Strategy C1 A (GSCAX) — Int/Div — Sold

Merger Fund Investor C1{MERFX) — None — Sold

Oppenheimer Developing Markets C1 A {ODMAX) — None — Sold

Oppenheimer Intl Bond Cl A (OIBAX) — Int/Div — Sold

Pimeo Foreign Bond Unhedged C1 A (PURAX) — Int/Div — Sold

Prudential Global Real Estate C1 A (PURAX) — Int/Div — Sold

Undiscovered Managers Behavioral Value A {UBVAN) — Int/Div — Sold

Vanguard FTSE Developed Markets ETF (VEA) — Int/Div — Sold

Wells Fargo Short Term High Yield Bond Cl AISSTHX) — Int/Div — Sold

Vanguard Large Cap ETF IV (VV) (X) — Int/Div — Sold

Accenture PLC Class A — Int/Div — Buy

Adient PLC — None — Buy

Adient PLC — Sold

Check PT Software — None — Buy

Cognizant Tech Solu Class A — None — Buy

CR Bard Incorporate — Int/Div — Buy

CVS Health Corp — Int/Div — Buy

Danaher Corp — None — Buy

Ecolab Inc — Int/Div — Buy

Expeditors Intl Wash — Int/Div — Buy

Fastenal Co — Int/Div — Buy

Fedex Corporation — Int/Div — Buy

Frunklin Resources — None — Buy

Minots Tool Works — None — Buy

Johnson & Johnson — Int/Div — Buy

Johnson Ctls Intl — None — Buy

Medtronic PLC — Int/Div — Buy

Microsoft Corp — Int/Div — Buy

Novartis AG ADR — None — Buy

Proctor & Gamble — Int/Div — Buy

Qualcomm Inc — Int/Div — Buy

Sherwin Williams Co — Int/Div — Buy

Stryker Corp — None — Buy

Thermo Fisher Sentfe — Int/Div — Buy

Visa Inc Class A — Int/Div — Buy

Wal-mart Stores Inc — Int/Div — Buy

WW Grainger Inc — Int/Div — Buy

Past President, Federal Bar Association, Mmnesota Chapter

Committee Member, NCBE, Multistate Bar Drafting Committee

President, Jimmie V. Revna Intellectual Property lon of Court

Reimbursement — Duke Law School — June 26-28, 2016 — Washington, DX — MDL Panelist — Transportation, hotel, and meals

Reimbursement — NCBE — October 26-28. 2016 — Newport, RI — Multistate Bar Drafting Committee Meeting — Transportation, hotel, and meals

Income — 2016 — National Conterence of Bar Examiners — S7.000.00

In the 2016 report, assets were sorted by account and identified with individual headers. As a result, lines 9 and 47 of the 2016 report both correspond with lines

25-29 of the 2015 report, and lines 11 and 52 of the 2016 report both correspond with lines 38-41 of the 2015 report

Part VII, lines 3-4, 7-9, 14-16, and 20-21 of the 2015 report were sold in their entirety during 2015,

Part VII, lines 29, 37, 41, and 44 of the 2015 report should have reflected "Sold (part)” instead of "Sold."

Part VIL, line 24 of the 2015 report is a defined benefit pension plan and thercofre was removed from Part VIL It continues to be listed in Part 11, and when

payments are made, they will be reflected in Part II A.